United States· US:62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659
Tavaborole
A tavaborole product containing tavaborole, registered in United States by Alembic Pharmaceuticals Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TAVABOROLE
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- D01AE24
- ATC class
- Tavaborole
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1162332467041 BOTTLE, DROPPER in 1 CARTON (62332-467-04) / 4 mL in 1 BOTTLE, DROPPER
- ndc1162332467101 BOTTLE, DROPPER in 1 CARTON (62332-467-10) / 10 mL in 1 BOTTLE, DROPPER
- ndc1162332-467-04
- ndc1162332-467-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D01AE24
Tavaborole, as other registers publish it.
- United StatestavaboroleMayne Pharma Commercial LLC
- United StatesTavaboroleChartwell RX, LLC
- United StatesTavaboroleAlembic Pharmaceuticals Limited
- United StatesTavaboroleAmneal Pharmaceuticals NY LLC
- United StatesTavaboroleEncube Ethicals, Inc.
- United StatesTavaboroleViona Pharmaceuticals Inc
- United StatesTavaboroleZydus Lifesciences Limited
- United StatesTAVABOROLECipla USA Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4d49980c-034e-4378-ba3b-c786355a6e25 GET /v1/drugs/4d49980c-034e-4378-ba3b-c786355a6e25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "43.5",
"substance": "TAVABOROLE",
"productndc": "62332-467",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA212188",
"marketing_category": "ANDA"
}See everything about tavaborole.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.